Enfortumab vedotin/Pembrolizumab: Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease: case report

View at publisher Summarise with VIRAT
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Reactions Weekly
Volume
2102
Issue
1
Pages
81–81
Publication date
21 March 2026
Language
EN